KKNSAKiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc trades on Nasdaq under the ticker KNSA. The company belongs to the Health care sector. The trading history on this page starts on 25 May 2018.

Over the past 52 weeks KNSA has traded between 35.20 $ and 82.94 $. As of 09 October 2026 the price stood 93.38 % of the way from the 52-week low to the high.

Over one year KNSA shares rose 108.25 %; over six months they rose 69.46 %. Volatility over 90 days is 51.48 %. Dividends are not included: this is price change only, as of 09 October 2026.

KNSA trades at a price-to-earnings ratio of 90.0, above the sector median of 25.0. Price to sales is 8.7, above the sector median of 4.0. Price to book is 10.9, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.

Kiniksa Pharmaceuticals International, plc reported revenue of 754M $ and net income of 73M $ over the last four quarters. Net margin is 9.69 %. Revenue changed by +56.71 % year over year. Earnings per share are 0.91 $. Market capitalisation is 6.6B $.

KNSA has a return on equity of 12.06 %, above the sector median of −41.68 %. Return on assets is 8.85 %, above the sector median of −32.11 %. Operating margin is 12.36 %, above the sector median of −26.84 %.